Skip to content

Effect of Scalp Nerve Block on the Recovery Quality of Parkinson's Patients After Deep Brain Stimulation

Effect of Scalp Nerve Block Combined With Intercostal Nerve Block on Quality of Recovery After Deep Brain Stimulation in Patients With Parkinson's Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05353764
Enrollment
88
Registered
2022-04-29
Start date
2022-04-20
Completion date
2023-03-01
Last updated
2022-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Patients diagnosed with Parkinson's disease (PD) undergoing deep Brain Stimulation (DBS) have a higher risk of perioperative complications and postoperative pain will affect quality of recovery (QoR) resulting in longer hospitalization time and higher hospital costs. Scalp nerve block (SNB) combined with intercostal nerve block (ICNB)can alleviate postoperative pain while effect of them on postoperative recovery quality of patients diagnosed with PD was unclear. Therefore, the investigators conducted a randomized controlled trails to provide a novel method for enhanced recovery and early prevention and treatment of acute pain after DBS surgery.

Interventions

OTHERscalp nerve block combined with intercostal nerve block using 0.5% ropivacaine

Participants randomized to the SNB group will receive general anesthesia combined with scalp nerve block and intercostal nerve block with 0.5% ropivacaine, which was performed exclusively by an attending anesthesiologist.An attending anesthesiologist will select the site of SNB based on the surgical incision site. Scalp nerve was blocked including greater occipital nerve (2-3ml), superficial temporal nerve (2-3ml), trochlear nerve (2-3ml) and supraorbital nerve (2-3ml). The total volume in scalp nerve block will not exceed 10 ml.Ultrasound-guided unilateral ICNB will be performed at the level of T4-T5 next to the sternum.10-15ml of 0.5% ropivacaine will be injected into the intercostal spaces where incision locates after negative aspiration.

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* patients with PD who receive elective deep brain stimulation (DBS) surgery * Aged ≥ 18 * American Society of Anesthesiologists (ASA) physical status of I-III * Able to communicate normally

Exclusion criteria

* Allergy to local anesthetics * Pre-existing infection at block site * Severe coagulopathy * Pre-existing neuropathic pain condition * Previous history of DBS surgery * unwilling to provide informed consent or poor compliance

Design outcomes

Primary

MeasureTime frameDescription
The 15-item QoR score24 hour after surgeryThe 15-item QoR score is used to asses quality of recovery after surgery which ranges 0-150 and higher QoR-15 scores indicate better postoperative recovery

Secondary

MeasureTime frameDescription
The 15-item QoR score72 hour and 1 month after surgeryThe 15-item QoR score is used to asses quality of recovery after surgery which ranges 0-150 and higher QoR-15 scores indicate better postoperative recovery
The NRS scorebefore discharge from PACU, at 24 hour, 72 hour and 1 month after surgeryPostoperative pain will be quantified using the NRS ranging from 0 to 10, where 0 means no pain at all and 10 means the worst pain imaginable
The patients with PONV24 hour after surgerypostoperative nausea and vomiting
Consumption of opioidduring operationThe consumption of opioid reffers to remifentanil consumption

Countries

China

Contacts

Primary ContactWenbin Lu
13004162573@163.com13004162573
Backup ContactXiya Yu, M.D
yuxiyash@163.com13764210333

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026